Document:

<PAGE>   1

                                                                     EXHIBIT 4.1

                          REGISTRATION RIGHTS AGREEMENT

            THIS REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of
February 20, 2001 between Hoskin International Limited ("Purchaser") and
e-Medsoft.com (the "Company").

            WHEREAS, simultaneously with the execution and delivery of this
Agreement, the parties are entering into a Common Stock Purchase Agreement,
dated as of the date hereof (the "Purchase Agreement"), by and between the
Purchaser and the Company, the Purchaser has committed to purchase up to
$25,000,000 of the Company's Common Stock (terms not defined herein shall have
the meanings ascribed to them in the Purchase Agreement) and the Warrant; and

            WHEREAS, the execution and delivery of this Agreement granting to
the Purchaser the registration rights set forth herein with respect to the
Shares is a component part of the transaction contemplated under the Purchase
Agreement.

            NOW, THEREFORE, the parties hereto mutually agree as follows:

            Section 1. Registrable Securities. As used herein the term
"Registrable Security" means all Shares that have not been (i) sold under the
Registration Statement, (ii) sold under circumstances under which all of the
applicable conditions of Rule 144 (or any similar provision then in force) under
the Securities Act ("Rule 144") are met, (iii) otherwise transferred to persons
who may trade such Shares without restriction under the Securities Act, and the
Company has delivered a new certificate or other evidence of ownership for such
Shares not bearing a restrictive legend or (iv) sold without any time, volume or
manner limitations pursuant to Rule 144(k) (or any similar provision then in
effect) under the Securities Act. In the event of any merger, reorganization,
consolidation, recapitalization or other change in corporate structure affecting
the Common Stock, such adjustment shall be deemed to be made in the definition
of "Registrable Security" as is appropriate in order to prevent any dilution or
enlargement of the rights granted pursuant to this Agreement.

            Section 2. Restrictions on Transfer. The Purchaser acknowledges and
understands that in the absence of an effective Registration Statement
authorizing the resale of the Shares as provided herein, the Shares are
"restricted securities" as defined in Rule 144. The Purchaser understands that
no disposition or transfer of the Shares may be made by Purchaser in the absence
of (i) an opinion of counsel to the Purchaser, in form and substance reasonably
satisfactory to the Company, that such transfer may be made without registration
under the Securities Act, or (ii) such registration.

            With a view to making available to the Purchaser the benefits of
Rule 144, the Company agrees to:

               (a) comply with the provisions of paragraph (c)(1) of Rule 144;
        and

<PAGE>   2

               (b) file with the Commission in a timely manner all reports and
        other documents required to be filed by the Company pursuant to Section
        13 or 15(d) under the Exchange Act; and, if at any time it is not
        required to file such reports but in the past had been required to or
        did file such reports, it will, upon the request of the Purchaser, make
        available other information as required by, and so long as necessary to
        permit sales of, its Registrable Securities pursuant to Rule 144.

            Section 3. Registration Rights With Respect to the Shares.

               (a) The Company agrees that it will prepare and file with the
        Securities and Exchange Commission ("Commission"), within forty-five
        (45) days after the date hereof, a registration statement (on Form S-3
        and/or S-1, or other appropriate form of registration statement) under
        the Securities Act (the "Registration Statement"), at the sole expense
        of the Company (except as provided in Section 3(d) hereof, so as to
        permit a public offering and resale of the Shares under the Securities
        Act by Purchaser.

               (b) The Company shall use its best efforts to cause the
        Registration Statement to become effective within the earlier of (i)
        ninety (90) days of the date hereof, or (ii) five (5) days after
        receiving written notice of SEC clearance and will within said five (5)
        days request acceleration of effectiveness. The Company will notify
        Purchaser of the effectiveness of the Registration Statement within one
        Trading Day of such event.

               (c) The Company will maintain the Registration Statement or
        post-effective amendment filed under this Section 3 hereof effective
        under the Securities Act until the earliest of (i) the date that all the
        Shares have been disposed of pursuant to the Registration Statement,
        (ii) the date that all of the Shares have been sold pursuant to the
        Registration Statement, (iii) all Shares have been otherwise transferred
        to persons who may trade such shares without restriction under the
        Securities Act, and the Company has delivered a new certificate or other
        evidence of ownership for such Shares not bearing a restrictive legend,
        (iv) all Shares may be sold without any time, volume or manner
        limitations pursuant to Rule 144(k) or any similar provision then in
        effect under the Securities Act in the opinion of counsel to the
        Company, which counsel shall be reasonably acceptable to the Purchaser,
        or (v) 20 months after the Effective Date, provided that the Company
        gives the investor 10 Trading Days' notice that the Registration
        Statement shall no longer be effective (the "Effectiveness Period").

               (d) All fees, disbursements and out-of-pocket expenses and costs
        incurred by the Company in connection with the preparation and filing of
        the Registration Statement under subparagraph 3(a) and in complying with
        applicable securities and Blue Sky laws (including, without limitation,
        all attorneys' fees of the Company) shall be borne by the Company. The
        Purchaser shall bear the cost of underwriting and/or brokerage
        discounts, fees and commissions, if any, applicable to the Shares being
        registered and the fees and expenses of its counsel.

               (e) The Purchaser and its counsel shall have a reasonable period,
        not to exceed five (5) Trading Days, to review the proposed Registration
        Statement or any

                                       2
<PAGE>   3

        amendment thereto, prior to filing with the Commission, and the Company
        shall provide the Purchaser with copies of any comment letters received
        from the Commission with respect thereto within two (2) Trading Days of
        receipt thereof.

               (f) The Company shall make reasonably available for inspection by
        Purchaser, any underwriter participating in any disposition pursuant to
        the Registration Statement, and any attorney, accountant or other agent
        retained by the Purchaser or any such underwriter all relevant financial
        and other records, pertinent corporate documents and properties of the
        Company and its subsidiaries, and cause the Company's officers,
        directors and employees to supply all information reasonably requested
        by the Purchaser or any such underwriter, attorney, accountant or agent
        in connection with the Registration Statement, in each case, as is
        customary for due diligence examinations; provided, however, all
        records, information and documents that are designated in writing by the
        Company, in good faith, as confidential, proprietary or containing any
        material non-public information shall be kept confidential by the
        Purchaser and any such underwriter, attorney, accountant or agent (and,
        upon the reasonable request of the Company, as a condition to the
        Purchaser's right to receive such information hereunder, such
        underwriters, attorneys, accountants and agents, as may be applicable,
        shall enter into confidentiality agreements in a form reasonably
        acceptable to the Company), unless such disclosure is made pursuant to
        judicial process in a court proceeding (after first giving the Company
        an opportunity promptly to seek a protective order or otherwise limit
        the scope of the information sought to be disclosed) or is required by
        law, or such records, information or documents become available to the
        public generally or through a third party not in violation of an
        accompanying obligation of confidentiality. If the foregoing inspection
        and information gathering would otherwise disrupt the Company's conduct
        of its business, such inspection and information gathering shall, to the
        maximum extent possible, be coordinated on behalf of the Purchaser and
        the other parties entitled thereto by one firm of counsel designed by
        and on behalf of the majority in interest of Purchaser and other
        parties.

               (g) The Company shall qualify any of the Shares for sale in such
        states as the Purchaser reasonably designates and shall furnish
        indemnification in the manner provided in Section 6 hereof. However, the
        Company shall not be required to qualify in any state which will require
        an escrow or other restriction relating to the Company and/or the
        sellers, or which will require the Company to qualify to do business in
        such state or require the Company to file therein any general consent to
        service of process.

               (h) The Company at its expense will supply the Purchaser with
        copies of the Registration Statement and the included therein (the
        "Prospectus") and other related documents in such quantities as may be
        reasonably requested by the Purchaser.

               (i) The Company shall not be required by this Section 3 to
        include a Purchaser's Shares in any Registration Statement which is to
        be filed if, in the opinion of counsel for both the Purchaser and the
        Company (or, should they not agree, in the opinion of another counsel
        experienced in securities law matters acceptable to counsel for the
        Purchaser and the Company) the proposed offering or other transfer as to
        which such

                                       3
<PAGE>   4

        registration is requested is exempt from applicable federal and state
        securities laws and would result in all purchasers or transferees
        obtaining securities which are not "restricted securities", as defined
        in Rule 144 under the Securities Act.

               (j) If at any time or from time to time after the effective date
        of the Registration Statement, the Company notifies the Purchaser in
        writing of the existence of a Potential Material Event (as defined in
        Section 3(k) below), the Purchaser shall not offer or sell any Shares or
        engage in any other transaction involving or relating to Shares, from
        the time of the giving of notice with respect to a Potential Material
        Event until the Purchaser receives written notice from the Company that
        such Potential Material Event either has been disclosed to the public or
        no longer constitutes a Potential Material Event (the "Suspension
        Period"). Notwithstanding anything herein to the contrary, if a
        Suspension Period occurs during any Draw Down Pricing Period or during
        the ten (10) Trading Days immediately following the end of any Draw Down
        Pricing Period, the Company must compensate the Purchaser for any net
        decline in the market value of any Shares (i) purchased by the Purchaser
        pursuant to the most recently completed Draw Down Pricing Period, and
        (ii) sold by the Purchaser during the ten (10) Trading Days immediately
        following the end of such Suspension period. Net decline shall be
        calculated as the difference between the highest VWAP during the
        Suspension Period and the average price at which the Purchaser sold the
        Shares in accordance with (ii) above. If a Potential Material Event
        shall occur prior to the date the Registration Statement is filed, then
        the Company's obligation to file the Registration Statement shall be
        delayed without penalty for not more than thirty (30) calendar days. THE
        COMPANY MUST GIVE PURCHASER NOTICE OF THE EXISTENCE OF A POTENTIAL
        MATERIAL EVENT IN WRITING AT LEAST TWO (2) TRADING DAYS PRIOR TO THE
        FIRST DAY OF ANY SUSPENSION PERIOD, IF LAWFUL TO DO SO.

               (k) "Potential Material Event" means any of the following: (i)
        the possession by the Company of material information that is not ripe
        for disclosure in a registration statement, as determined in good faith
        by the Chief Executive Officer or the Board of Directors of the Company
        or that disclosure of such information in the Registration Statement
        would be detrimental to the business and affairs of the Company; or (ii)
        any material engagement or activity by the Company which would, in the
        good faith determination of the Chief Executive Officer or the Board of
        Directors of the Company, be adversely affected by disclosure in a
        registration statement at such time, which determination shall be
        accompanied by a good faith determination by the Chief Executive Officer
        or the Board of Directors of the Company that the Registration Statement
        would be materially misleading absent the inclusion of such information.

            Section 4. Cooperation with Company. The Purchaser shall cooperate
with the Company in all respects in connection with this Agreement, including
timely supplying all information reasonably requested by the Company (which
shall include all information regarding the Purchaser and proposed manner of
sale of the Registrable Securities required to be disclosed in the Registration
Statement) and executing and returning all documents reasonably requested in
connection with the registration and sale of the Registrable Securities and
entering into and performing its obligations under any underwriting agreement,
if the offering is an underwritten offering, in usual and customary form, with
the managing underwriter or underwriters of such

                                       4
<PAGE>   5

underwritten offering. The Purchaser shall consent to be named as an underwriter
in the Registration Statement. Purchaser acknowledges that in accordance with
current Commission policy, the Purchaser will be named as the underwriter of the
Shares in the Registration Statement.

            Section 5. Registration Procedures. If and whenever the Company is
required by any of the provisions of this Agreement to effect the registration
of any of the Registrable Securities under the Securities Act, the Company shall
(except as otherwise provided in this Agreement), as expeditiously as possible,
subject to the Purchaser's assistance and cooperation as reasonably required:

               (a) prepare and file with the Commission such amendments and
        supplements to the Registration Statement and the Prospectus as may be
        necessary to keep such registration statement effective and to comply
        with the provisions of the Securities Act with respect to the sale or
        other disposition of all securities covered by such registration
        statement whenever the Purchaser of such Registrable Securities shall
        desire to sell or otherwise dispose of the same (including prospectus
        supplements with respect to the sales of securities from time to time in
        connection with a registration statement pursuant to Rule 415
        promulgated under the Securities Act) and (ii) take all lawful action
        such that each of (A) the Registration Statement and any amendment
        thereto does not, when it becomes effective, contain an untrue statement
        of a material fact or omit to state a material fact required to be
        stated therein or necessary to make the statements therein not
        misleading and (B) the Prospectus, and any amendment or supplement
        thereto, does not at any time during the Effectiveness Period include an
        untrue statement of a material fact or omit to state a material fact
        required to be stated therein or necessary to make the statements
        therein, in light of the circumstances under which they were made, not
        misleading;

               (b) prior to the filing with the Commission of any Registration
        Statement (including any amendments thereto) and the distribution or
        delivery of any Prospectus (including any supplements thereto), provide
        draft copies thereof to the Purchaser and reflect in such documents all
        such comments as the Purchaser (and its counsel) reasonably may propose
        and (ii) furnish to the Purchaser such numbers of copies of the
        Prospectus including a preliminary prospectus or any amendment or
        supplement to any Prospectus, as applicable, in conformity with the
        requirements of the Securities Act, and such other documents, as the
        Purchaser may reasonably request in order to facilitate the public sale
        or other disposition of the Registrable Securities;

               (c) comply with New York blue sky laws with respect to the
        Registrable Securities (subject to the limitations set forth in Section
        3(g) above), and do any and all other acts and things which may be
        reasonably necessary or advisable to enable the Purchaser to consummate
        the public sale or other disposition in such jurisdiction of the
        Registrable Securities;

               (d) list such Registrable Securities on the Principal Market, and
        any other exchange on which the Common Stock of the Company is then
        listed, if the listing

                                       5
<PAGE>   6

        of such Registrable Securities is then permitted under the rules of such
        exchange or the Nasdaq Stock Market;

               (e) notify the Purchaser at any time when the Prospectus relating
        thereto covered by the Registration Statement is required to be
        delivered under the Securities Act, of the happening of any event of
        which it has knowledge as a result of which the Prospectus, as then in
        effect, includes an untrue statement of a material fact or omits to
        state a material fact required to be stated therein or necessary to make
        the statements therein not misleading in the light of the circumstances
        then existing, and the Company shall prepare and file a curative
        amendment under Section 5(a) as quickly as commercially possible;

               (f) as promptly as practicable after becoming aware of such
        event, notify the Purchaser (or, in the event of an underwritten
        offering, the managing underwriters) of the issuance by the Commission
        or any state authority of any stop order or other suspension of the
        effectiveness of the Registration Statement at the earliest possible
        time and take all lawful action to effect the withdrawal, rescission or
        removal of such stop order or other suspension;

               (g) cooperate with the Purchaser to facilitate the timely
        preparation and delivery of certificates for the Registrable Securities
        to be offered pursuant to the Registration Statement and enable such
        certificates for the Registrable Securities to be in such denominations
        or amounts, as the case may be, as the Purchaser reasonably may request
        and registered in such names as the Purchaser may request, pursuant to
        the Purchase Agreement.

               (h) take all such other lawful actions reasonably necessary to
        expedite and facilitate the disposition by the Purchaser of its
        Registrable Securities in accordance with the intended methods therefor
        provided in the Prospectus which are customary for issuers to perform
        under the circumstances;

               (i) in the event of an underwritten offering, promptly include or
        incorporate in a Prospectus supplement or post-effective amendment to
        the Registration Statement such information as the managing underwriters
        reasonably agree should be included therein and to which the Company
        does not reasonably object and make all required filings of such
        prospectus supplement or post-effective amendment as soon as practicable
        after it is notified of the matters to be included or incorporated in
        such prospectus supplement or post-effective amendment; and

               (j) maintain a transfer agent for its Common Stock.

            Section 6. Indemnification.

               (a) The Company agrees to indemnify and hold harmless the
        Purchaser and each person, if any, who controls the Purchaser within the
        meaning of the Securities Act ("Distributing Purchaser") against any
        losses, claims, damages or liabilities, joint or

                                       6
<PAGE>   7

        several (which shall, for all purposes of this Agreement, include, but
        not be limited to, all reasonable costs of defense and investigation and
        all reasonable attorneys' fees), to which the Distributing Purchaser may
        become subject, under the Securities Act or otherwise, insofar as such
        losses, claims, damages or liabilities (or actions in respect thereof)
        arise out of or are based upon any untrue statement or alleged untrue
        statement of any material fact contained in the Registration Statement,
        or any related preliminary prospectus, the Prospectus or amendment or
        supplement thereto, or arise out of or are based upon the omission or
        alleged omission to state therein a material fact required to be stated
        therein or necessary to make the statements therein not misleading;
        provided, however, that the Company will not be liable in any such case
        to the extent that any such loss, claim, damage or liability arises out
        of or is based upon an untrue statement or alleged untrue statement or
        omission or alleged omission made in the Registration Statement,
        preliminary prospectus, the Prospectus or amendment or supplement
        thereto in reliance upon, and in conformity with, written information
        furnished to the Company by the Distributing Purchaser specifically for
        use in the preparation thereof. This Section 6(a) shall not inure to the
        benefit of any Distributing Purchaser with respect to any person
        asserting such loss, claim, damage or liability who purchased the
        Registrable Securities which are the subject thereof if the Distributing
        Purchaser failed to send or give (in violation of the Securities Act or
        the rules and regulations promulgated thereunder) a copy of the
        Prospectus to such person at or prior to the written confirmation to
        such person of the sale of such Registrable Securities, where the
        Distributing Purchaser was obligated to do so under the Securities Act
        or the rules and regulations promulgated thereunder.

               (b) Each Distributing Purchaser agrees that it will indemnify and
        hold harmless the Company, and each officer, director of the Company or
        person, if any, who controls the Company within the meaning of the
        Securities Act, against any losses, claims, damages or liabilities
        (which shall, for all purposes of this Agreement, include, but not be
        limited to, all reasonable costs of defense and investigation and all
        reasonable attorneys' fees) to which the Company or any such officer,
        director or controlling person may become subject under the Securities
        Act or otherwise, insofar as such losses, claims, damages or liabilities
        (or actions in respect thereof) arise out of or are based upon any
        untrue statement or alleged untrue statement of any material fact
        contained in the Registration Statement, or any related preliminary
        prospectus, the Prospectus or amendment or supplement thereto, or arise
        out of or are based upon the omission or the alleged omission to state
        therein a material fact required to be stated therein or necessary to
        make the statements therein not misleading, but in each case only to the
        extent that such untrue statement or alleged untrue statement or
        omission or alleged omission was made in the Registration Statement,
        preliminary prospectus, the Prospectus or amendment or supplement
        thereto in reliance upon, and in conformity with, written information
        furnished to the Company by such Distributing Purchaser specifically for
        use in the preparation thereof. Notwithstanding anything to the contrary
        herein, the Distributing Purchaser shall not be liable under this
        Section 6(b) for any amount in excess of the net proceeds to such
        Distributing Purchaser as a result of the sale of Registrable Securities
        pursuant to the Registration Statement.

                                       7
<PAGE>   8

               (c) Promptly after receipt by an indemnified party under this
        Section 6 of notice of the commencement of any action, such indemnified
        party will, if a claim in respect thereof is to be made against the
        indemnifying party under this Section 6, notify the indemnifying party
        of the commencement thereof; but the omission so to notify the
        indemnifying party will not relieve the indemnifying party from any
        liability which it may have to any indemnified party except to the
        extent of actual prejudice demonstrated by the indemnifying party. In
        case any such action is brought against any indemnified party, and it
        notifies the indemnifying party of the commencement thereof, the
        indemnifying party will be entitled to participate in, and, to the
        extent that it may wish, jointly with any other indemnifying party
        similarly notified, assume the defense thereof, subject to the
        provisions herein stated and after notice from the indemnifying party to
        such indemnified party of its election so to assume the defense thereof,
        the indemnifying party will not be liable to such indemnified party
        under this Section 6 for any legal or other expenses subsequently
        incurred by such indemnified party in connection with the defense
        thereof other than reasonable costs of investigation, unless the
        indemnifying party shall not pursue the action to its final conclusion.
        The indemnified party shall have the right to employ separate counsel in
        any such action and to participate in the defense thereof, but the fees
        and expenses of such counsel shall not be at the expense of the
        indemnifying party if the indemnifying party has assumed the defense of
        the action with counsel reasonably satisfactory to the indemnified
        party; provided that if the indemnified party is the Distributing
        Purchaser, the fees and expenses of such counsel shall be at the expense
        of the indemnifying party if (i) the employment of such counsel has been
        specifically authorized in writing by the indemnifying party, or (ii)
        the named parties to any such action (including any impleaded parties)
        include both the Distributing Purchaser and the indemnifying party and
        the Distributing Purchaser shall have been advised by such counsel that
        there may be one or more legal defenses available to the indemnifying
        party different from or in conflict with any legal defenses which may be
        available to the Distributing Purchaser (in which case the indemnifying
        party shall not have the right to assume the defense of such action on
        behalf of the Distributing Purchaser, it being understood, however, that
        the indemnifying party shall, in connection with any one such action or
        separate but substantially similar or related actions in the same
        jurisdiction arising out of the same general allegations or
        circumstances, be liable only for the reasonable fees and expenses of
        one separate firm of attorneys for the Distributing Purchaser, which
        firm shall be designated in writing by the Distributing Purchaser and be
        approved by the indemnifying party). No settlement of any action against
        an indemnified party shall be made without the prior written consent of
        the indemnified party, which consent shall not be unreasonably withheld.

               All fees and expenses of the indemnified party (including
        reasonable costs of defense and investigation in a manner not
        inconsistent with this Section and all reasonable attorneys' fees and
        expenses) shall be paid to the indemnified party, as incurred, within
        ten (10) Trading Days of written notice thereof to the indemnifying
        party; provided, that the indemnifying party may require such
        indemnified party to undertake to reimburse all such fees and expenses
        to the extent it is finally judicially determined that such indemnified
        party is not entitled to indemnification hereunder.

                                       8
<PAGE>   9

            Section 7. Contribution. In order to provide for just and equitable
contribution under the Securities Act in any case in which (i) the indemnified
party makes a claim for indemnification pursuant to Section 6 hereof but is
judicially determined (by the entry of a final judgment or decree by a court of
competent jurisdiction and the expiration of time to appeal or the denial of the
last right of appeal) that such indemnification may not be enforced in such case
notwithstanding the fact that the express provisions of Section 6 hereof provide
for indemnification in such case, or (ii) contribution under the Securities Act
may be required on the part of any indemnified party, then the Company and the
applicable Distributing Purchaser shall contribute to the aggregate losses,
claims, damages or liabilities to which they may be subject (which shall, for
all purposes of this Agreement, include, but not be limited to, all reasonable
costs of defense and investigation and all reasonable attorneys' fees), in
either such case (after contribution from others) on the basis of relative fault
as well as any other relevant equitable considerations. The relative fault shall
be determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company on the one hand
or the applicable Distributing Purchaser on the other hand, and the parties'
relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission. The Company and the Distributing Purchaser
agree that it would not be just and equitable if contribution pursuant to this
Section 7 were determined by pro rata allocation or by any other method of
allocation which does not take account of the equitable considerations referred
to in this Section 7. The amount paid or payable by an indemnified party as a
result of the losses, claims, damages or liabilities (or actions in respect
thereof) referred to above in this Section 7 shall be deemed to include any
legal or other expenses reasonably incurred by such indemnified party in
connection with investigating or defending any such action or claim. No person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the Securities Act) shall be entitled to contribution from any person who was
not guilty of such fraudulent misrepresentation.

            Notwithstanding any other provision of this Section 7, in no event
shall any (i) Purchaser be required to undertake liability to any person under
this Section 7 for any amounts in excess of the dollar amount of the net
proceeds to be received by the Purchaser from the sale of the Purchaser's
Registrable Securities (after deducting any fees, discounts and commissions
applicable thereto) pursuant to any Registration Statement under which such
Registrable Securities are to be registered under the Securities Act and (ii)
underwriter be required to undertake liability to any person hereunder for any
amounts in excess of the aggregate discount, commission or other compensation
payable to such underwriter with respect to the Registrable Securities
underwritten by it and distributed pursuant to the Registration Statement.

            Section 8. Notices. All notices, demands, requests, consents,
approvals, and other communications required or permitted hereunder shall be in
writing and, unless otherwise specified herein, shall be delivered as set forth
in the Purchase Agreement.

            Section 9. Assignment. Neither this Agreement nor any rights of the
Purchaser or the Company hereunder may be assigned by either party to any other
person. Notwithstanding the foregoing, (a) the provisions of this Agreement
shall inure to the benefit of, and be enforceable by, any transferee of any of
the Common Stock purchased by the Purchaser

                                       9
<PAGE>   10

pursuant to the Purchase Agreement other than through open-market sales, and (b)
upon the prior written consent of the Company, which consent shall not be
unreasonably withheld or delayed in the case of an assignment to an affiliate of
the Purchaser, the Purchaser's interest in this Agreement may be assigned at any
time, in whole or in part, to any other person or entity (including any
affiliate of the Purchaser) who agrees to be bound hereby.

            Section 10. Counterparts/Facsimile. This Agreement may be executed
in two or more counterparts, each of which shall constitute an original, but all
of which, when together shall constitute but one and the same instrument, and
shall become effective when one or more counterparts have been signed by each
party hereto and delivered to the other party. In lieu of the original, a
facsimile transmission or copy of the original shall be as effective and
enforceable as the original.

            Section 11. Remedies and Severability. The remedies provided in this
Agreement are cumulative and not exclusive of any remedies provided by law. If
any term, provision, covenant or restriction of this Agreement is held by a
court of competent jurisdiction to be invalid, illegal, void or unenforceable,
the remainder of the terms, provisions, covenants and restrictions set forth
herein shall remain in full force and effect and shall in no way be affected,
impaired or invalidated, and the parties hereto shall use their best efforts to
find and employ an alternative means to achieve the same or substantially the
same result as that contemplated by such term, provision, covenant or
restriction.

            Section 12. Conflicting Agreements. The Company shall not enter into
any agreement with respect to its securities that is inconsistent with the
rights granted to the purchasers of Registrable Securities in this Agreement or
otherwise prevents the Company from complying with all of its obligations
hereunder.

            Section 13. Headings. The headings in this Agreement are for
reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement.

            Section 14. Governing Law. Governing Law/Arbitration. This Agreement
shall be governed by and construed in accordance with the internal laws of the
State of California, without giving effect to the choice of law provisions. The
Company and the Purchaser agree to submit themselves to the in personam
jurisdiction of the state and federal courts situated within the the State of
California with regard to any controversy arising out of or relating to this
Agreement. Any dispute under this Agreement shall be submitted to arbitration
under the commercial rules of the American Arbitration Association (the "AAA")
in San Francisco, California, and shall be finally and conclusively determined
by the decision of a board of arbitration consisting of three (3) members
(hereinafter referred to as the "Board of Arbitration") selected as according to
the rules governing the AAA. The Board of Arbitration shall meet on consecutive
business days in San Francisco, California, and shall reach and render a
decision in writing (concurred in by a majority of the members of the Board of
Arbitration) with respect to the amount, if any, which the losing party is
required to pay to the other party in respect of a claim filed. In connection
with rendering its decisions, the Board of Arbitration shall adopt and follow
the laws of the State of California. To the extent practical, decisions of the
Board of Arbitration shall be rendered no more than thirty (30) calendar days
following commencement of proceedings with

                                       10
<PAGE>   11

respect thereto. The Board of Arbitration shall cause its written decision to be
delivered to all parties involved in the dispute. The Board of Arbitration shall
be authorized and is directed to enter a default judgment against any party
refusing to participate in the arbitration proceeding within thirty days of any
deadline for such participation. Any decision made by the Board of Arbitration
(either prior to or after the expiration of such thirty (30) calendar day
period) shall be final, binding and conclusive on the parties to the dispute,
and entitled to be enforced to the fullest extent permitted by law and entered
in any court of competent jurisdiction. The prevailing party shall be awarded
its costs, including attorneys' fees, from the non-prevailing party as part of
the arbitration award. Any party shall have the right to seek injunctive relief
from any court of competent jurisdiction in any case where such relief is
available. The prevailing party in such injunctive action shall be awarded its
costs, including reasonable attorneys' fees, from the non-prevailing party.

                            [SIGNATURE PAGE FOLLOWS]

                                       11
<PAGE>   12

            IN WITNESS WHEREOF, the parties hereto have caused this Registration
Rights Agreement to be duly executed, on this 20th day of February, 2001

                                   E-MEDSOFT.COM

                                   By:  /s/ John Andrews
                                        ----------------------------------------
                                          John Andrews, President & CEO

                                   HOSKIN INTERNATIONAL LIMITED

                                   By:  /s/ David Sims
                                        ----------------------------------------
                                          David Sims, Authorized Signatory

                                       12<PAGE>   1
                                                                     EXHIBIT 4.2

NEITHER THIS WARRANT NOR THE SHARES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")
OR ANY OTHER APPLICABLE SECURITIES LAWS IN RELIANCE UPON AN EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH OTHER SECURITIES LAWS.
NEITHER THIS WARRANT NOR THE SHARES ISSUABLE UPON EXERCISE HEREOF MAY BE SOLD,
PLEDGED, TRANSFERRED, ENCUMBERED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR IN A TRANSACTION
WHICH IS EXEMPT FROM REGISTRATION UNDER THE PROVISIONS OF THE SECURITIES ACT AND
ANY APPLICABLE STATE LAWS.

                             STOCK PURCHASE WARRANT

                 To Purchase 626,292 Shares of Common Stock of

                                  E-MEDSOFT.COM

            THIS CERTIFIES that, for value received, Hoskin International
Limited (the "Holder"), is entitled, upon the terms and subject to the
limitations on exercise and the conditions hereinafter set forth, at any time on
or after the Initial Exercise Date (as defined below) and on or prior to the
close of business on the Termination Date (as defined below) but not thereafter,
to subscribe for and purchase from e-MedSoft.com, a corporation incorporated in
the State of Nevada (the "Company"), up to 626,292 shares (the "Warrant Shares")
of Common Stock, $0.001 par value per share, of the Company (the "Common
Stock"). The purchase price of one share of Common Stock (the "Exercise Price")
under this Warrant shall be $1.9959. The Exercise Price and the number of
Warrant Shares for which the Warrant is exercisable shall be subject to
adjustment as provided herein. In the event of any conflict between the terms of
this Warrant and the Common Stock Purchase Agreement dated as of February 20,
2001 pursuant to which this Warrant has been issued (the "Purchase Agreement"),
the Purchase Agreement shall control. Capitalized terms used and not otherwise
defined herein shall have the meanings set forth for such terms in the Purchase
Agreement.

                                       1
<PAGE>   2

            1. Title to Warrant. Prior to the Termination Date and subject to
compliance with applicable laws, this Warrant and all rights hereunder are
transferable, in whole or in part, at the office or agency of the Company by the
Holder in person or by duly authorized attorney, upon surrender of this Warrant
together with the Assignment Form annexed hereto properly endorsed.

            2. Authorization of Shares. The Company covenants that all Warrant
Shares which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this
Warrant, be duly authorized, validly issued, fully paid and nonassessable and
free from all taxes, liens and charges in respect of the issue thereof (other
than taxes in respect of any transfer occurring contemporaneously with such
issue).

            3. Exercise of Warrant.

               (a) Except as provided in Section 4 herein, exercise of the
        purchase rights represented by this Warrant may be made at any time or
        times (i) on or after the earlier to occur of (A) 180 calendar days from
        the date hereof, and (B) the Effective Date (the "Initial Exercise
        Date"), and, (ii) on or before the earlier of (A) the close of business
        on February 20, 2006, and (B) the date on which the Commission declares,
        as a matter of general policy, that it will no longer permit the
        registration of the resale of shares purchased pursuant to any "equity
        line" arrangement, provided that such declaration occurs within 180
        calendar days from the date hereof (the "Termination Date") by the
        surrender of this Warrant and the Notice of Exercise Form annexed hereto
        duly executed, at the office of the Company (or such other office or
        agency of the Company as it may designate by notice in writing to the
        registered Holder at the address of such Holder appearing on the books
        of the Company) and upon payment of the Exercise Price of the shares
        thereby purchased by wire transfer or cashier's check drawn on a United
        States bank or by means of a cashless exercise, the Holder shall be
        entitled to receive a certificate for the number of Warrant Shares so
        purchased. Notwithstanding anything to the contrary herein, sub-section
        (a)(ii)(B) above shall have no force and effect (i) with regard to
        comments received by the commission that may be cured by obtaining
        waivers from the Purchaser or by withdrawing the Registration Statement
        and amending any of the Transaction Documents, or (ii) in the event the
        Registration Statement is declared effective. Certificates for shares
        purchased hereunder shall be delivered to the Holder within three (3)
        Trading Days after the date on which this Warrant shall have been
        exercised as aforesaid. This Warrant shall be deemed to have been
        exercised and such certificate or certificates shall be deemed to have
        been issued, and Holder or any other person so designated to be named
        therein shall be deemed to have become a holder of record of such shares
        for all purposes, as of the date the Warrant has been exercised by
        payment to the Company of the Exercise Price and all taxes required to
        be paid by the Holder, if any, pursuant to Section 5 prior to the
        issuance of such shares, have been paid.

               (b) If this Warrant shall have been exercised in part, the
        Company shall, at the time of delivery of the certificate or
        certificates representing Warrant Shares,

                                       2
<PAGE>   3

        deliver to Holder a new Warrant evidencing the rights of Holder to
        purchase the unpurchased Warrant Shares called for by this Warrant,
        which new Warrant shall in all other respects be identical with this
        Warrant.

               (c) This Warrant shall also be exercisable by means of a
        "cashless exercise" in which the Holder shall be entitled to receive a
        certificate for the number of Warrant Shares equal to the quotient
        obtained by dividing [(A-B) (X)] by (A), where:

               (A) = the average of the high and low trading prices per share of
               Common Stock on the Trading Day preceding the date of such
               election on the Nasdaq Stock Market, or if the Common Stock is
               not traded on the Nasdaq Stock Market, then the Principal Market
               in terms of volume;

               (B) = the Exercise Price of this Warrant; and

               (X) = the number of Warrant Shares issuable upon exercise of this
               Warrant in accordance with the terms of this Warrant and the
               Notice of Exercise.

               (d) Notwithstanding anything herein to the contrary, in no event
        shall the Holder be permitted to exercise this Warrant for Warrant
        Shares to the extent that (i) the number of shares of Common Stock owned
        by such Holder (other than Warrant Shares issuable upon exercise of this
        Warrant) plus (ii) the number of Warrant Shares issuable upon exercise
        of this Warrant, would be equal to or exceed 9.9% of the number of
        shares of Common Stock then issued and outstanding, including shares
        issuable upon exercise of this Warrant held by such Holder after
        application of this Section 3(d). As used herein, beneficial ownership
        shall be determined in accordance with Section 13(d) of the Exchange
        Act. To the extent that the limitation contained in this Section 3(d)
        applies, the determination of whether this Warrant is exercisable (in
        relation to other securities owned by the Holder) and of which a portion
        of this Warrant is exercisable shall be in the sole discretion of such
        Holder, and the submission of a Notice of Exercise shall be deemed to be
        such Holder's determination of whether this Warrant is exercisable (in
        relation to other securities owned by such Holder) and of which portion
        of this Warrant is exercisable, in each case subject to such aggregate
        percentage limitation, and the Company shall have no obligation to
        verify or confirm the accuracy of such determination. Nothing contained
        herein shall be deemed to restrict the right of a Holder to exercise
        this Warrant into Warrant Shares at such time as such exercise will not
        violate the provisions of this Section 3(d). The provisions of this
        Section 3(d) may be waived by the Holder upon, at the election of the
        Holder, with not less than 61 days' prior notice to the Company, and the
        provisions of this Section 3(d) shall continue to apply until such 61st
        day (or such later date as may be specified in such notice of waiver).
        No exercise of this Warrant in violation of this Section 3(d) but
        otherwise in accordance with this Warrant shall affect the status of the
        Warrant Shares as validly issued, fully-paid and nonassessable.

            4. No Fractional Shares or Scrip. No fractional shares or scrip
representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share

                                       3
<PAGE>   4

which Holder would otherwise be entitled to purchase upon such exercise, the
Company shall pay a cash adjustment in respect of such final fraction in an
amount equal to such fraction multiplied by the Exercise Price.

            5. Charges, Taxes and Expenses. Issuance of certificates for Warrant
Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such certificate, all
of which taxes and expenses shall be paid by the Company, and such certificates
shall be issued in the name of the Holder or in such name or names as may be
directed by the Holder; provided, however, that in the event certificates for
Warrant Shares are to be issued in a name other than the name of the Holder,
this Warrant when surrendered for exercise shall be accompanied by the
Assignment Form attached hereto duly executed by the Holder; and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it
for any transfer tax incidental thereto.

            6. Closing of Books. Unless required by law, the Company will not
close its stockholder books or records in any manner which prevents the timely
exercise of this Warrant.

            7. Transfer, Division and Combination.

               (a) Subject to compliance with any applicable securities laws,
        transfer of this Warrant and all rights hereunder, in whole or in part,
        shall be registered on the books of the Company to be maintained for
        such purpose, upon surrender of this Warrant at the principal office of
        the Company, together with a written assignment of this Warrant
        substantially in the form attached hereto duly executed by the Holder or
        its agent or attorney and funds sufficient to pay any transfer taxes
        payable upon the making of such transfer. In the event that the Holder
        wishes to transfer a portion of this Warrant, the Holder shall transfer
        at least 100,000 shares underlying this Warrant to any such transferee.
        Upon such surrender and, if required, such payment, the Company shall
        execute and deliver a new Warrant or Warrants in the name of the
        assignee or assignees and in the denomination or denominations specified
        in such instrument of assignment, and shall issue to the assignor a new
        Warrant evidencing the portion of this Warrant not so assigned, and this
        Warrant shall promptly be cancelled. A Warrant, if properly assigned,
        may be exercised by a new holder for the purchase of Warrant Shares
        without having a new Warrant issued.

               (b) This Warrant may be divided or combined with other Warrants
        upon presentation hereof at the aforesaid office of the Company,
        together with a written notice specifying the names and denominations in
        which new Warrants are to be issued, signed by the Holder or its agent
        or attorney. Subject to compliance with Section 7(a), as to any transfer
        which may be involved in such division or combination, the Company shall
        execute and deliver a new Warrant or Warrants in exchange for the
        Warrant or Warrants to be divided or combined in accordance with such
        notice.

               (c) The Company shall prepare, issue and deliver at its own
        expense (other than transfer taxes) the new Warrant or Warrants under
        this Section 7.

                                       4
<PAGE>   5

               (d) The Company agrees to maintain, at its aforesaid office,
        books for the registration and the registration of transfer of the
        Warrants.

            8. No Rights as Shareholder until Exercise. This Warrant does not
entitle the Holder to any voting rights or other rights as a shareholder of the
Company prior to the exercise hereof. Upon the surrender of this Warrant and the
payment of the aggregate Exercise Price or by means of a cashless exercise, the
Warrant Shares so purchased shall be and be deemed to be issued to such Holder
as the record owner of such shares as of the close of business on the later of
the date of such surrender or payment.

            9. Loss, Theft, Destruction or Mutilation of Warrant. The Company
covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock
certificate relating to the Warrant Shares, and in case of loss, theft or
destruction, of indemnity or security reasonably satisfactory to it (which shall
not include the posting of any bond), and upon surrender and cancellation of
such Warrant or stock certificate, if mutilated, the Company will make and
deliver a new Warrant or stock certificate of like tenor and dated as of such
cancellation, in lieu of such Warrant or stock certificate.

            10. Saturdays, Sundays, Holidays, etc. If the last or appointed day
for the taking of any action or the expiration of any right required or granted
herein shall be a Saturday, Sunday or a legal holiday, then such action may be
taken or such right may be exercised on the next succeeding day not a Saturday,
Sunday or legal holiday.

            11. Adjustments of Exercise Price and Number of Warrant Shares. (a)
Stock Splits, etc. The number and kind of securities purchasable upon the
exercise of this Warrant and the Exercise Price shall be subject to adjustment
from time to time upon the happening of any of the following. In case the
Company shall (i) pay a dividend in shares of Common Stock or make a
distribution in shares of Common Stock to holders of its outstanding Common
Stock, (ii) subdivide its outstanding shares of Common Stock into a greater
number of shares, (iii) combine its outstanding shares of Common Stock into a
smaller number of shares of Common Stock, or (iv) issue any shares of its
capital stock in a reclassification of the Common Stock, then the number of
Warrant Shares purchasable upon exercise of this Warrant immediately prior
thereto shall be adjusted so that the Holder shall be entitled to receive the
kind and number of Warrant Shares or other securities of the Company which it
would have owned or have been entitled to receive had such Warrant been
exercised in advance thereof. Upon each such adjustment of the kind and number
of Warrant Shares or other securities of the Company which are purchasable
hereunder, the Holder shall thereafter be entitled to purchase the number of
Warrant Shares or other securities resulting from such adjustment at an Exercise
Price per Warrant Share or other security obtained by multiplying the Exercise
Price in effect immediately prior to such adjustment by the number of Warrant
Shares purchasable pursuant hereto immediately prior to such adjustment and
dividing by the number of Warrant Shares or other securities of the Company
resulting from such adjustment. An adjustment made pursuant to this paragraph
shall become effective immediately after the effective date of such event
retroactive to the record date, if any, for such event.

                                       5
<PAGE>   6

            12. Reorganization, Reclassification, Merger, Consolidation or
Disposition of Assets. In case the Company shall reorganize its capital,
reclassify its capital stock, consolidate or merge with or into another
corporation (where the Company is not the surviving corporation or where there
is a change in or distribution with respect to the Common Stock of the Company),
or sell, transfer or otherwise dispose of all or substantially all its property,
assets or business to another corporation and, pursuant to the terms of such
reorganization, reclassification, merger, consolidation or disposition of
assets, shares of common stock of the successor or acquiring corporation, or any
cash, shares of stock or other securities or property of any nature whatsoever
(including warrants or other subscription or purchase rights) in addition to or
in lieu of common stock of the successor or acquiring corporation ("Other
Property"), are to be received by or distributed to the holders of Common Stock
of the Company, then the Holder shall have the right thereafter to receive, upon
exercise of this Warrant, the number of shares of Common Stock of the successor
or acquiring corporation or of the Company, if it is the surviving corporation,
and Other Property receivable upon or as a result of such reorganization,
reclassification, merger, consolidation or disposition of assets by a Holder of
the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such event. In case of any such reorganization,
reclassification, merger, consolidation or disposition of assets, the successor
or acquiring corporation (if other than the Company) shall expressly assume the
due and punctual observance and performance of each and every covenant and
condition of this Warrant to be performed and observed by the Company and all
the obligations and liabilities hereunder, subject to such modifications as may
be deemed appropriate (as determined in good faith by resolution of the Board of
Directors of the Company) in order to provide for adjustments of Warrant Shares
for which this Warrant is exercisable which shall be as nearly equivalent as
practicable to the adjustments provided for in this Section 12. For purposes of
this Section 12, "common stock of the successor or acquiring corporation" shall
include stock of such corporation of any class which is not preferred as to
dividends or assets over any other class of stock of such corporation and which
is not subject to redemption and shall also include any evidences of
indebtedness, shares of stock or other securities which are convertible into or
exchangeable for any such stock, either immediately or upon the arrival of a
specified date or the happening of a specified event and any warrants or other
rights to subscribe for or purchase any such stock. The foregoing provisions of
this Section 12 shall similarly apply to successive reorganizations,
reclassifications, mergers, consolidations or disposition of assets.
Notwithstanding anything to the contrary in this Section 12, a successor or
acquiring corporation, at the closing of the succession or acquisition of the
Company, may elect to purchase the entire unexercised portion of this Warrant at
the value for such warrant as determined in accordance with the Black-Scholes
option pricing formula; provided, however, the successor or acquiring
corporation notify the Holder at least ten (10) Trading Days prior to such
closing. The Holder shall have the right to exercise all or any portion of this
Warrant up to and including the Trading Day immediately prior to the date set in
such notice for the purchase of this Warrant.

            13. Voluntary Adjustment by the Company. The Company may at any time
during the term of this Warrant reduce the then current Exercise Price to any
amount and for any period of time deemed appropriate by the Board of Directors
of the Company.

            14. Notice of Adjustment. Whenever the number of Warrant Shares or
number or kind of securities or other property purchasable upon the exercise of
this Warrant or the Exercise Price is adjusted, as herein provided, the Company
shall promptly mail by registered

                                       6
<PAGE>   7

or certified mail, return receipt requested, to the Holder notice of such
adjustment or adjustments setting forth the number of Warrant Shares (and other
securities or property) purchasable upon the exercise of this Warrant and the
Exercise Price of such Warrant Shares (and other securities or property) after
such adjustment, setting forth a brief statement of the facts requiring such
adjustment and setting forth the computation by which such adjustment was made.
Such notice, in the absence of manifest error, shall be conclusive evidence of
the correctness of such adjustment.

            15. Notice of Corporate Action. If at any time:

                    (a) the Company shall take a record of the holders of its
        Common Stock for the purpose of entitling them to receive a dividend or
        other distribution, or any right to subscribe for or purchase any
        evidences of its indebtedness, any shares of stock of any class or any
        other securities or property, or to receive any other right, or

                    (b) there shall be any capital reorganization of the
        Company, any reclassification or recapitalization of the capital stock
        of the Company or any consolidation or merger of the Company with, or
        any sale, transfer or other disposition of all or substantially all the
        property, assets or business of the Company to, another corporation or,

                    (c) there shall be a voluntary or involuntary dissolution,
        liquidation or winding up of the Company;

then, in any one or more of such cases, the Company shall give to Holder (i) at
least 20 days' prior written notice of the date on which a record date shall be
selected for such dividend, distribution or right or for determining rights to
vote in respect of any such reorganization, reclassification, merger,
consolidation, sale, transfer, disposition, liquidation or winding up, and (ii)
in the case of any such reorganization, reclassification, merger, consolidation,
sale, transfer, disposition, dissolution, liquidation or winding up, at least 20
days' prior written notice of the date when the same shall take place. Such
notice in accordance with the foregoing clause also shall specify (i) the date
on which any such record is to be taken for the purpose of such dividend,
distribution or right, the date on which the holders of Common Stock shall be
entitled to any such dividend, distribution or right, and the amount and
character thereof, and (ii) the date on which any such reorganization,
reclassification, merger, consolidation, sale, transfer, disposition,
dissolution, liquidation or winding up is to take place and the time, if any
such time is to be fixed, as of which the holders of Common Stock shall be
entitled to exchange their Warrant Shares for securities or other property
deliverable upon such disposition, dissolution, liquidation or winding up. Each
such written notice shall be sufficiently given if addressed to Holder at the
last address of Holder appearing on the books of the Company and delivered in
accordance with Section 17(d).

            16. Authorized Shares. The Company covenants that during the period
the Warrant is outstanding, it will reserve from its authorized and unissued
Common Stock a sufficient number of shares to provide for the issuance of the
Warrant Shares upon the exercise of any purchase rights under this Warrant. The
Company further covenants that its issuance of

                                       7
<PAGE>   8

this Warrant shall constitute full authority to its officers who are charged
with the duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may be
necessary to assure that such Warrant Shares may be issued as provided herein
without violation of any applicable law or regulation, or of any requirements of
the Principal Market upon which the Common Stock may be listed.

                The Company shall not by any action, including, without
limitation, amending its certificate of incorporation or through any
reorganization, transfer of assets, consolidation, merger, dissolution, issue or
sale of securities or any other voluntary action, avoid or seek to avoid the
observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the
taking of all such actions as may be necessary or appropriate to protect the
rights of Holder against impairment. Without limiting the generality of the
foregoing, the Company will (a) not increase the par value of any Warrant Shares
above the amount payable therefor upon such exercise immediately prior to such
increase in par value, (b) take all such action as may be necessary or
appropriate in order that the Company may validly and legally issue fully paid
and nonassessable Warrant Shares upon the exercise of this Warrant, and (c) use
commercially reasonable efforts to obtain all such authorizations, exemptions or
consents from any public regulatory body having jurisdiction thereof as may be
necessary to enable the Company to perform its obligations under this Warrant.

                Before taking any action which would result in an adjustment in
the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions
thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.

            17. Miscellaneous.

               (a) Jurisdiction. This Warrant shall constitute a contract under
        the laws of California, without regard to its conflict of law,
        principles or rules, and be subject to arbitration pursuant to the terms
        set forth in the Purchase Agreement.

               (b) Restrictions. The Holder acknowledges that the Warrant Shares
        acquired upon the exercise of this Warrant, if not registered, will have
        restrictions upon resale imposed by state and federal securities laws.

               (c) Nonwaiver and Expenses. No course of dealing or any delay or
        failure to exercise any right hereunder on the part of Holder shall
        operate as a waiver of such right or otherwise prejudice Holder's
        rights, powers or remedies, notwithstanding all rights hereunder
        terminate on the Termination Date. If the Company willfully and
        knowingly fails to comply with any provision of this Warrant, which
        results in any material damages to the Holder, the Company shall pay to
        Holder such amounts as shall be sufficient to cover any costs and
        expenses including, but not limited to, reasonable attorneys' fees,
        including those of appellate proceedings, incurred by Holder in
        collecting any amounts due pursuant hereto or in otherwise enforcing any
        of its rights, powers or remedies hereunder.

                                       8
<PAGE>   9

               (d) Notices. Any notice, request or other document required or
        permitted to be given or delivered to the Holder by the Company shall be
        delivered in accordance with the notice provisions of the Purchase
        Agreement.

               (e) Limitation of Liability. No provision hereof, in the absence
        of affirmative action by Holder to purchase Warrant Shares, and no
        enumeration herein of the rights or privileges of Holder, shall give
        rise to any liability of Holder for the purchase price of any Common
        Stock or as a stockholder of the Company, whether such liability is
        asserted by the Company or by creditors of the Company.

               (f) Remedies. Holder, in addition to being entitled to exercise
        all rights granted by law, including recovery of damages, will be
        entitled to specific performance of its rights under this Warrant. The
        Company agrees that monetary damages would not be adequate compensation
        for any loss incurred by reason of a breach by it of the provisions of
        this Warrant and hereby agrees to waive the defense in any action for
        specific performance that a remedy at law would be adequate.

               (g) Successors and Assigns. Subject to applicable securities
        laws, this Warrant and the rights and obligations evidenced hereby shall
        inure to the benefit of and be binding upon the successors of the
        Company and the successors and permitted assigns of Holder. Subject to
        compliance with applicable securities laws, the provisions of this
        Warrant are intended to be for the benefit of all Holders from time to
        time of this Warrant and shall be enforceable by any such Holder or
        holder of Warrant Shares.

               (h) Amendment. This Warrant may be modified or amended or the
        provisions hereof waived with the written consent of the Company and the
        Holder.

               (i) Severability. Wherever possible, each provision of this
        Warrant shall be interpreted in such manner as to be effective and valid
        under applicable law, but if any provision of this Warrant shall be
        prohibited by or invalid under applicable law, such provision shall be
        ineffective to the extent of such prohibition or invalidity, without
        invalidating the remainder of such provisions or the remaining
        provisions of this Warrant.

               (j) Headings. The headings used in this Warrant are for the
        convenience of reference only and shall not, for any purpose, be deemed
        a part of this Warrant.

                                       9
<PAGE>   10

            IN WITNESS WHEREOF, the Company has caused this Warrant to be
executed by its officer thereunto duly authorized.

Dated: February 20, 2001

                              E-MEDSOFT.COM

                              By:  /s/ John Andrews
                                   ---------------------------------------------
                                       John Andrews, President & CEO

                                       10
<PAGE>   11

                               NOTICE OF EXERCISE

To:     e-MedSoft.com

            (1) The undersigned hereby elects to purchase ________ Warrant
Shares (the "Common Stock"), of e-MedSoft.com pursuant to the terms of the
attached Warrant, and tenders herewith payment of the exercise price in full,
together with all applicable transfer taxes, if any.

            (2) Please issue a certificate or certificates representing said
Warrant Shares in the name of the undersigned or in such other name as is
specified below:

            -------------------------------------------

The Warrant Shares shall be delivered to the following:

            -------------------------------------------

            -------------------------------------------

            -------------------------------------------

                                             [PURCHASER]

                                             By:
                                                   -----------------------------
                                                   Name:
                                                   Title:

                                             Dated:
                                                   -----------------------------

<PAGE>   12

                   NOTICE OF EXERCISE OF COMMON STOCK WARRANT
                    PURSUANT TO CASHLESS EXERCISE PROVISIONS

To: e-MedSoft.com

Aggregate Price of Warrant Before Exercise:  $_______
Aggregate Price Being Exercised:  $______
Exercise Price:  $______ per share
Number of Shares of Common Stock to be Issued Under this Notice:  ________
Remaining Aggregate Price (if any) After Issuance:  $_______

Gentlemen:

            The undersigned, registered Holder of the Warrant delivered
herewith, hereby irrevocably exercises such Warrant for, and purchases
thereunder, shares of the Common Stock of e-MedSoft.com, a Nevada corporation,
as provided below. Capitalized terms used herein, unless otherwise defined
herein, shall have the meanings given in the Warrant. The portion of the
Exercise Price (as defined in the Warrant) to be applied toward the purchase of
Common Stock pursuant to this Notice of Exercise is $_______, thereby leaving a
remaining Exercise Price (if any) equal to $________. Such exercise shall be
pursuant to the cashless exercise provisions of Section 3 of the Warrant;
therefore, Holder makes no payment with this Notice of Exercise. The number of
shares to be issued pursuant to this exercise shall be determined by reference
to the formula in Section 3 of the Warrant which, by reference to Section 3,
requires the use of the high and low trading price of the Company's Common Stock
on the Trading Day preceding the date of such election. The high and low trading
price of the Company's Common Stock has been determined by Holder to be $______
and $_________, respectively, which figure is acceptable to Holder for
calculations of the number of shares of Common Stock issuable pursuant to this
Notice of Exercise. Holder requests that the certificates for the purchased
shares of Common Stock be issued in the name of _________________________ and
delivered to ______________________________________________. To the extent the
foregoing exercise is for less than the full Aggregate Price of the Warrant, a
replacement Warrant representing the remainder of the Aggregate Price (and
otherwise of like form, tenor and effect) shall be delivered

                                       2
<PAGE>   13

to Holder along with the share certificate evidencing the Common Stock issued in
response to this Notice of Exercise.

                                        [Purchaser]

                                        By:
                                            ------------------------------------
                                            Name:
                                            Title:

                                        Date:

                                      NOTE

            The execution to the foregoing Notice of Exercise must exactly
correspond to the name of the Holder on the Warrant

                                       3
<PAGE>   14

                                 ASSIGNMENT FORM

                    (To assign the foregoing warrant, execute
                   this form and supply required information.
                 Do not use this form to exercise the warrant.)

            FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced
thereby are hereby assigned to

________________________________________________________ whose address is

________________________________________________________________________.

_________________________________________________________________________

                                                 Dated:  ______________, _______

                      Holder's Signature:   _____________________________

                      Holder's Address:     _____________________________

                                            _____________________________

Signature Guaranteed:  __________________________________________________

NOTE: The signature to this Assignment Form must correspond with the name as it
appears on the face of the Warrant, without alteration or enlargement or any
change whatsoever, and must be guaranteed by a bank or trust company. Officers
of corporations and those acting in an fiduciary or other representative
capacity should file proper evidence of authority to assign the foregoing
Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00020-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00020-of-00352.parquet"}]]